{"id":224056,"date":"2026-08-31T13:32:59","date_gmt":"2026-08-31T08:02:59","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=224056"},"modified":"2026-08-31T13:33:01","modified_gmt":"2026-08-31T08:03:01","slug":"abbott-india-overvalued-or-undervalued","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/abbott-india-overvalued-or-undervalued\/","title":{"rendered":"Is Abbott India Overvalued or Undervalued Right Now?"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>Abbott India CMP Rs 26,070.00 (31 Aug 2026), down 0.40%. PE 34.61 vs industry PE 51.43. ROE 32.51%. 52W range Rs 25,150.00 to Rs 32,775.00.<\/em><\/p>\n<div style=\"background: #F0F9FF; border-left: 4px solid #2E7D32; border-radius: 6px; padding: 14px 18px; margin: 18px 0;\">\n<p style=\"margin: 0; color: #1f4e79; font-size: 14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin: 8px 0 0;\">Abbott India trades at a price to earnings ratio of 34.61, well below the industry average of 51.43, which points toward undervaluation on a simple multiple basis. The stock&#8217;s 32.51% return on equity and Rs 2,246.68 book value per share suggest the market may be underpricing the underlying business relative to peers. Whether Abbott India is overvalued or undervalued right now depends on whether that discount reflects a genuine risk the market has priced in or simply a lack of investor attention. On valuation multiples alone, the stock currently sits below what the broader sector is priced at.<\/p>\n<\/div>\n<p>Is <a href=\"https:\/\/univest.in\/stocks\/abbotindia\/abbott-india-ltd-share-price-today\">Abbott India<\/a> overvalued or undervalued right now is a question worth asking given how its price to earnings ratio compares with the rest of its sector. At the current market price of Rs 26,070.00, the stock trades roughly 20.5% below its 52 week high of Rs 32,775.00 and about 3.7% above its 52 week low of Rs 25,150.00.<\/p>\n<p>Abbott India&#8217;s share price moved down 0.40% in Monday&#8217;s session to Rs 26,070.00, against a market capitalisation of Rs 55,878 Cr. This article looks at the numbers, the PE ratio, price to book, return on equity, debt levels and recent earnings trends, that determine whether the current price reflects fair value or a stretched multiple.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=valn2\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-overvalued-or-undervalued\/#Abbott_India_Valuation_Metrics_Where_Does_the_Stock_Stand\" title=\"Abbott India Valuation Metrics: Where Does the Stock Stand?\">Abbott India Valuation Metrics: Where Does the Stock Stand?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-overvalued-or-undervalued\/#Is_Abbott_India_Overvalued_Based_on_Its_PE_Ratio\" title=\"Is Abbott India Overvalued Based on Its P\/E Ratio?\">Is Abbott India Overvalued Based on Its P\/E Ratio?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-overvalued-or-undervalued\/#Abbott_Indias_Financial_Growth_and_Profitability\" title=\"Abbott India&#8217;s Financial Growth and Profitability\">Abbott India&#8217;s Financial Growth and Profitability<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-overvalued-or-undervalued\/#Arguments_That_Abbott_India_Could_Be_Overvalued\" title=\"Arguments That Abbott India Could Be Overvalued\">Arguments That Abbott India Could Be Overvalued<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-overvalued-or-undervalued\/#Arguments_Against_a_Discount\" title=\"Arguments Against a Discount\">Arguments Against a Discount<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-overvalued-or-undervalued\/#Verdict_Is_Abbott_India_Overvalued_or_Undervalued_Right_Now\" title=\"Verdict: Is Abbott India Overvalued or Undervalued Right Now?\">Verdict: Is Abbott India Overvalued or Undervalued Right Now?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-overvalued-or-undervalued\/#What_Could_Change_This_Valuation_Picture_for_Abbott_India\" title=\"What Could Change This Valuation Picture for Abbott India?\">What Could Change This Valuation Picture for Abbott India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-overvalued-or-undervalued\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-overvalued-or-undervalued\/#FAQs_on_Abbott_India_Valuation\" title=\"FAQs on Abbott India Valuation\">FAQs on Abbott India Valuation<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-overvalued-or-undervalued\/#Is_Abbott_India_overvalued_or_undervalued_right_now\" title=\"Is Abbott India overvalued or undervalued right now?\">Is Abbott India overvalued or undervalued right now?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-overvalued-or-undervalued\/#What_is_Abbott_Indias_current_PE_ratio\" title=\"What is Abbott India&#8217;s current PE ratio?\">What is Abbott India&#8217;s current PE ratio?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-overvalued-or-undervalued\/#What_is_Abbott_Indias_return_on_equity\" title=\"What is Abbott India&#8217;s return on equity?\">What is Abbott India&#8217;s return on equity?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-overvalued-or-undervalued\/#What_is_Abbott_Indias_52_week_high_and_low\" title=\"What is Abbott India&#8217;s 52 week high and low?\">What is Abbott India&#8217;s 52 week high and low?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-overvalued-or-undervalued\/#Does_Abbott_India_have_high_debt\" title=\"Does Abbott India have high debt?\">Does Abbott India have high debt?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-overvalued-or-undervalued\/#What_is_Abbott_Indias_dividend_yield\" title=\"What is Abbott India&#8217;s dividend yield?\">What is Abbott India&#8217;s dividend yield?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-overvalued-or-undervalued\/#Is_Abbott_India_a_good_stock_to_buy_at_current_levels\" title=\"Is Abbott India a good stock to buy at current levels?\">Is Abbott India a good stock to buy at current levels?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/abbott-india-overvalued-or-undervalued\/#What_is_Abbott_Indias_price_to_book_ratio\" title=\"What is Abbott India&#8217;s price to book ratio?\">What is Abbott India&#8217;s price to book ratio?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Abbott_India_Valuation_Metrics_Where_Does_the_Stock_Stand\"><\/span><strong>Abbott India Valuation Metrics: Where Does the Stock Stand?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"border-collapse: collapse; width: 100%;\" border=\"1\" cellspacing=\"0\" cellpadding=\"6\">\n<tbody>\n<tr>\n<th>Valuation Metric<\/th>\n<th>Abbott India<\/th>\n<\/tr>\n<tr>\n<td>CMP (31 Aug 2026)<\/td>\n<td>Rs 26,070.00<\/td>\n<\/tr>\n<tr>\n<td>Market Cap<\/td>\n<td>Rs 55,878 Cr<\/td>\n<\/tr>\n<tr>\n<td>P\/E Ratio<\/td>\n<td>34.61<\/td>\n<\/tr>\n<tr>\n<td>Industry P\/E<\/td>\n<td>51.43<\/td>\n<\/tr>\n<tr>\n<td>P\/B Ratio<\/td>\n<td>11.70<\/td>\n<\/tr>\n<tr>\n<td>Sector Average P\/B (pharmaceutical)<\/td>\n<td>7.31<\/td>\n<\/tr>\n<tr>\n<td>Return on Equity (ROE)<\/td>\n<td>32.51%<\/td>\n<\/tr>\n<tr>\n<td>Sector Average ROE (pharmaceutical)<\/td>\n<td>12.94%<\/td>\n<\/tr>\n<tr>\n<td>EPS (TTM)<\/td>\n<td>Rs 759.85<\/td>\n<\/tr>\n<tr>\n<td>Book Value per Share<\/td>\n<td>Rs 2,246.68<\/td>\n<\/tr>\n<tr>\n<td>Debt to Equity<\/td>\n<td>0.04<\/td>\n<\/tr>\n<tr>\n<td>Dividend Yield<\/td>\n<td>2.49%<\/td>\n<\/tr>\n<tr>\n<td>Sector Average Dividend Yield (pharmaceutical)<\/td>\n<td>0.30%<\/td>\n<\/tr>\n<tr>\n<td>52 Week High \/ Low<\/td>\n<td>Rs 32,775.00 \/ Rs 25,150.00<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The headline number here is the price to earnings ratio. At 34.61, the Abbott India PE ratio is 0.67 times the industry average of 51.43. Measured against its pharmaceutical sector peers, the gap widens further on other measures too: a P\/B of 11.70 against a sector average of 7.31, and an ROE of 32.51% against a sector average of 12.94%.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Is_Abbott_India_Overvalued_Based_on_Its_PE_Ratio\"><\/span><strong>Is Abbott India Overvalued Based on Its P\/E Ratio?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Based on the P\/E ratio alone, Abbott India looks undervalued. The stock&#8217;s PE of 34.61 sits well below the industry average of 51.43, which can reflect either a genuine bargain or a market discounting some risk in the business that is not obvious from the ratio itself. Investors relying only on the PE ratio would classify Abbott India as cheaper than its peers, but the Abbott India PE ratio still needs to be read alongside its return ratios and earnings quality before concluding the stock is a genuine value opportunity.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check Abbott India&#8217;s Live Fundamentals on the Univest Screener<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Abbott_Indias_Financial_Growth_and_Profitability\"><\/span><strong>Abbott India&#8217;s Financial Growth and Profitability<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Abbott India&#8217;s revenue moved from Rs 4,938.99 crore in FY2024 to Rs 5,673.31 crore in FY2025, a change of 14.9%. Net profit grew from Rs 857.21 crore to Rs 1,052.99 crore over the same period, a swing of roughly 22.8%.<\/p>\n<p>The Abbott India share price has moved alongside this earnings trend, which is part of why the stock now trades at 0.67 times the industry PE of 51.43 rather than a flat multiple.<\/p>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Abbott India&#8217;s live share price and valuation ratios.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Arguments_That_Abbott_India_Could_Be_Overvalued\"><\/span><strong>Arguments That Abbott India Could Be Overvalued<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Rich price to book:<\/strong> A P\/B of 11.70 is well above the sector average of 7.31.<\/li>\n<li><strong>Limited margin of safety:<\/strong> At Rs 26,070.00, the stock is only 20.5% below its 52 week high of Rs 32,775.00, leaving less room for error if earnings disappoint.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Arguments_Against_a_Discount\"><\/span><strong>Arguments Against a Discount<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>High return on equity:<\/strong> ROE of 32.51% against a sector average of 12.94% reflects efficient use of shareholder capital.<\/li>\n<li><strong>Low leverage:<\/strong> A debt to equity ratio of 0.04 gives Abbott India a comparatively strong balance sheet.<\/li>\n<li><strong>Reasonable income:<\/strong> A dividend yield of 2.49% offers some cushion while the market decides on the growth story.<\/li>\n<li><strong>52 week range context:<\/strong> At Rs 26,070.00, the stock is 3.7% above its 52 week low of Rs 25,150.00, showing it has already found some support at lower levels.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Verdict_Is_Abbott_India_Overvalued_or_Undervalued_Right_Now\"><\/span><strong>Verdict: Is Abbott India Overvalued or Undervalued Right Now?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>On balance, Abbott India looks undervalued by traditional multiples, trading at a PE of 34.61 against an industry average of 51.43. That gap can close either through the share price catching up or through the business underperforming enough to justify the discount, so the read depends on which explanation fits the company&#8217;s recent earnings trend better. A 32.51% ROE is a reasonable starting point for that judgement, but investors should weigh why the market has kept the stock at a discount before treating the gap as a straightforward opportunity.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_Could_Change_This_Valuation_Picture_for_Abbott_India\"><\/span><strong>What Could Change This Valuation Picture for Abbott India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Two broad scenarios could shift this valuation call on Abbott India in either direction. On the upside, the market recognising the gap between the PE of 34.61 and the industry average of 51.43, which would show up as the share price re-rating higher without a change in earnings. On the downside, a genuine deterioration in the business that justifies the current discount, in which case the low PE would turn out to be a fair reflection of risk rather than a bargain. Investors watching the Abbott India share price over the next few quarters should track whether reported ROE holds near 32.51% and whether the PE gap versus the industry average of 51.43 widens or narrows, since both will matter more to the eventual answer than the current price point on its own.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Abbott India&#8217;s numbers point to a stock that is undervalued on headline multiples, though its return ratios help explain part of the gap. Investors tracking the Abbott India share price should watch whether earnings growth can keep pace with the current PE of 34.61, since that gap remains the single biggest variable in whether the stock is undervalued, fairly priced, or overvalued from here. This article is for informational purposes only and is not investment advice.<\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"FAQs_on_Abbott_India_Valuation\"><\/span><strong>FAQs on Abbott India Valuation<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Is_Abbott_India_overvalued_or_undervalued_right_now\"><\/span><strong>Is Abbott India overvalued or undervalued right now?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Based on a PE ratio of 34.61 against an industry average of 51.43, Abbott India currently looks undervalued on relative valuation. Its 32.51% ROE is an important part of the picture alongside the PE ratio.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Abbott_Indias_current_PE_ratio\"><\/span><strong>What is Abbott India&#8217;s current PE ratio?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Abbott India&#8217;s price to earnings ratio stands at 34.61, compared with an industry average PE of 51.43.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Abbott_Indias_return_on_equity\"><\/span><strong>What is Abbott India&#8217;s return on equity?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Abbott India generates a return on equity of 32.51%, against a sector average of 12.94% among pharmaceutical peers.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Abbott_Indias_52_week_high_and_low\"><\/span><strong>What is Abbott India&#8217;s 52 week high and low?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Abbott India&#8217;s 52 week high is Rs 32,775.00 and its 52 week low is Rs 25,150.00. The stock currently trades around Rs 26,070.00, roughly 20.5% below its high.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Does_Abbott_India_have_high_debt\"><\/span><strong>Does Abbott India have high debt?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Abbott India carries a debt to equity ratio of 0.04, which is low for its sector.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Abbott_Indias_dividend_yield\"><\/span><strong>What is Abbott India&#8217;s dividend yield?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Abbott India offers a dividend yield of 2.49% at the current share price.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Abbott_India_a_good_stock_to_buy_at_current_levels\"><\/span><strong>Is Abbott India a good stock to buy at current levels?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Abbott India&#8217;s current valuation suits investors who agree with the undervalued read on its PE ratio and are comfortable with the trade-off between its return ratios and its price. This is for informational purposes only and is not investment advice.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Abbott_Indias_price_to_book_ratio\"><\/span><strong>What is Abbott India&#8217;s price to book ratio?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Abbott India trades at a price to book ratio of 11.70, compared with a sector average of 7.31 among pharmaceutical peers.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Abbott India trades at a PE of 34.61 versus an industry average of 51.43. We break down its ROE, debt, and valuation ratios to assess if the stock is overvalued or undervalued right now.<\/p>\n","protected":false},"author":35,"featured_media":224055,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[3802],"class_list":["post-224056","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["224055"],"_edit_lock":["1788163384:29"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["24"],"rank_math_seo_score":["70"],"rank_math_title":["Abbott India Valuation Check: Overvalued or Undervalued?"],"rank_math_description":["Is Abbott India overvalued or undervalued right now? A look at its PE ratio, industry PE, ROE and book value versus CMP Rs 26,070.00 to judge the stock's valuation."],"rank_math_focus_keyword":["Abbott India"],"rank_math_robots":["a:2:{i:0;s:8:\"nofollow\";i:1;s:7:\"noindex\";}"],"_edit_last":["29"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["40512"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/abbott-india-overvalued-or-undervalued.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/224056","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=224056"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/224056\/revisions"}],"predecessor-version":[{"id":224111,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/224056\/revisions\/224111"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/224055"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=224056"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=224056"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=224056"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}